HCP, Inc. (HCP) Tops Q4 FFO by 2c

HCP, Inc. (NYSE: HCP) reported Q4 FFO of $0.59, $0.02 better than the analyst estimate of $0.57.

GUIDANCE:

HCP, Inc. sees Q1 2017 FFO of $1.89-$1.95, versus the consensus of $1.91.

EXECUTIVE LEADERSHIP

Our Board of Directors elected Tom Herzog as CEO and to serve as a member of the Board and also elected Justin Hutchens as President. Both elections were effective January 1, 2017.

Peter Scott joined the company as Executive Vice President and Chief Financial Officer, effective February 13, 2017.

For earnings history and earnings-related data on HCP, Inc. (HCP) click here.

You May Also Be Interested In

• Bristol-Myers Squibb and AstraZeneca said to discuss megamerger - can it happen?
• inTEST Corp (INTT) reported Q2 Revenue ; Offers Guidance
• Truist upgrades Corning to Buy after pullback, sees AI demand driving upside